Use of Direct Oral Anticoagulants Versus Traditional Therapies for Acute Venous Thromboembolism After Direct Discharge From the Emergency Department or After Hospitalization: An Audit of 16 Canadian Hospitals

2020 ◽  
Vol 42 (5) ◽  
pp. 873-881
Author(s):  
Tammy J. Bungard ◽  
Bruce Ritchie ◽  
Jennifer Bolt ◽  
Peter Thomson ◽  
William M. Semchuk
Keyword(s):  
Emergency Department ◽  
Venous Thromboembolism ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Traditional Therapies ◽  
Acute Venous Thromboembolism ◽  
Direct Discharge

scholarly journals Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism

Haematologica ◽  
2019 ◽  
Vol 105 (6) ◽  
pp. e307-e309 ◽  
Author(s):  
Maddie S. Stephen ◽  
Lana Castellucci ◽  
Marc Carrier ◽  
Lisa Duffett ◽  
Gregoire Le Gal ◽  
...  
Keyword(s):  
Venous Thromboembolism ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Diagnostic Workup ◽  
Acute Venous Thromboembolism

scholarly journals Persistence to direct oral anticoagulants for acute venous thromboembolism

2018 ◽  
Vol 167 ◽  
pp. 135-141 ◽  
Author(s):  
Charlotte E.A. Dronkers ◽  
Willem M. Lijfering ◽  
Martina Teichert ◽  
Felix J.M. van der Meer ◽  
Frederikus A. Klok ◽  
...  
Keyword(s):  
Venous Thromboembolism ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Acute Venous Thromboembolism

scholarly journals Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

Blood ◽  
2014 ◽  
Vol 124 (12) ◽  
pp. 1968-1975 ◽  
Author(s):  
Nick van Es ◽  
Michiel Coppens ◽  
Sam Schulman ◽  
Saskia Middeldorp ◽  
Harry R. Büller
Keyword(s):  
Venous Thromboembolism ◽  
Major Bleeding ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Similar Efficacy ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Key Points ◽  
Acute Venous Thromboembolism

Key Points DOACs have similar efficacy as VKAs in the treatment of acute symptomatic VTE, but significantly reduce the risk of major bleeding. The efficacy and safety of DOACs in the treatment of acute VTE are consistent in clinically important subgroups.

Sign in / Sign up

Export Citation Format

Share Document